Welcome to our dedicated page for Delek Us Hldgs SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Delek US Holdings, Inc. (NYSE: DK) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Delek US uses Form 8-K filings to furnish quarterly earnings releases, dividend announcements, investor presentations, and earnings call slides, giving investors a structured view of its financial condition and strategic messaging.
Through Item 2.02 of Form 8-K, Delek US reports results of operations and financial condition, including net income or loss, Adjusted net income, Adjusted EBITDA, and segment-level performance for refining and logistics. These filings often reference non-GAAP measures such as refining margin, adjusted refining margin, refining production margin, and net debt, along with reconciliations to GAAP metrics described in accompanying tables.
Item 7.01 Regulation FD disclosures in Delek US 8-Ks typically include earnings call slides and investor presentations. The company notes that these materials are furnished, not filed, and may be used in presentations to existing and prospective investors. Item 8.01 is used for other events, such as Board-approved quarterly dividends per share, with details on record and payment dates.
On this page, Stock Titan’s AI summarizes the key points from each filing so users can quickly understand what changed in Delek US’s business, capital allocation, and midstream relationship with Delek Logistics Partners, LP. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while AI-generated highlights help clarify complex sections, such as non-GAAP definitions and regulatory language, without replacing the need to review the full original documents.
Delek US Holdings EVP and CFO Mark Wayne Hobbs reported stock-based compensation activity involving the company’s common stock. On March 9–10, he acquired multiple share awards at no cash cost to him, including grants tied to the vesting of performance-based and time-vesting restricted stock units.
The filing also shows 6,388 shares were disposed of through share withholding to cover tax obligations upon vesting, rather than through open-market sales. After these transactions, Hobbs directly holds 125,149 shares of Delek US Holdings common stock.
Delek US Holdings EVP Israel Joseph reported equity compensation-related transactions in company common stock. On March 6, he received 4,301 shares as a grant or award, tied to the vesting of performance-based restricted stock units. That same day, 1,693 shares were withheld at $42.29 per share to cover tax obligations on the vesting.
On March 9, an additional 353 shares were withheld at $40.13 per share for tax purposes. After these transactions, Joseph directly held 57,878 shares of Delek US common stock. The dispositions reflect tax-withholding mechanics rather than open-market sales.
Delek US Holdings is asking stockholders to vote at its virtual 2026 annual meeting on April 20, 2026. Holders of 59,808,421 common shares as of February 27, 2026 can vote online, by phone, mail, or during the webcast.
Stockholders will elect ten directors, cast an advisory vote on executive compensation, approve a new 2026 Long-Term Incentive Plan, and ratify Ernst & Young as independent auditor. The board is majority independent, uses a lead independent director structure, and has five key committees overseeing audit, compensation, governance, ESG, technology, and cyber risk.
The filing details extensive ESG and risk oversight, board refreshment efforts, and a pay-for-performance program tying annual and long-term incentives to financial and strategic goals. In 2025 Delek returned $141.4 million to stockholders through dividends and buybacks and highlights acquisitions and cost initiatives as performance drivers for executive pay decisions.
DK reports notice of securities sales by an affiliate. The filing lists prior sales by Shlomo Zohar: 7,343 common shares sold on 03/04/2026 for $315,749.00 and 22,029 common shares sold on 03/05/2026 for $987,633.50.
The submission also lists multiple scheduled restricted stock vesting entries (2020–2021) and a broker/agent record showing 5,000 common shares associated with Fidelity Brokerage Services LLC.
Delek US Holdings director Ezra Uzi Yemin reported open-market sales of Delek common stock. On March 4, 2026, he sold 18,139 directly owned shares at a weighted average price of $43.17 per share, leaving 240,281 shares held directly.
On the same date, 66,511 shares were sold indirectly through Yemin Investments, LP at the same weighted average price, with 613,145 shares remaining held indirectly. The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on December 3, 2025, using multiple trades between $43.00 and $43.57 per share.
Delek US Holdings director Zohar Shlomo reported open‑market sales of company common stock under a pre‑arranged trading plan. On March 4–5, 2026, he sold a total of 29,372 shares of Delek US Holdings common stock in several transactions at prices between $43.00 and $45.50 per share. Following these sales, he directly owned 18,989 shares of the company’s common stock. The filing notes that these transactions were made pursuant to a Rule 10b5‑1 trading plan adopted on November 13, 2025, intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c).
Delek US Holdings EVP Israel Joseph reported an open-market sale of 38,000 shares of common stock on March 4, 2026 at a weighted average price of $40.65 per share. After this transaction, he directly owned 55,623 shares of Delek US common stock.
The reported price reflects multiple trades with individual sale prices ranging from $40.10 to $40.93 per share, aggregated into a single weighted average figure for disclosure.
Delek US Holdings, Inc. executive vice president of special projects Reuven Spiegel reported an open-market sale of common stock. On March 4, 2026, he sold 20,000 shares at a weighted average price of $42.84 per share, in multiple trades between $42.80 and $42.98. After this sale, he directly owned 48,530 shares of Delek US common stock.
Delek US Holdings, Inc. director William J. Finnerty sold 5,392 shares of common stock in an open‑market transaction at $42.75 per share on March 4, 2026, leaving him with 46,369 directly owned shares after the sale.